Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Vor Biopharma Inc. Financials Banner

Vor Biopharma Inc. Financials

VOR Stock Analysis

Page title

Section title

VOR Income Statement Key Metrics

  • Revenue(TTM)12.23 M
  • Gross Profit(TTM)7.40 M
  • EBITDA(TTM)-122.07 M
  • Net Income(TTM)-118.09 M
  • EPS Diluted(TTM)-1.74

Decode VOR's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

VOR earnings and revenue history

VOR Return on Equity

See how efficiently VOR generates profit for it's shareholders.

-78.20%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of VOR (-0.782) is lower than the average of its peers (-0.425).

Return on Equity Growth

VOR's Return on Equity has shown poor growth over the past 10 years, increasing by only -4.13%.

VOR Revenue Growth

See how VOR has grown it's revenue over the past 10 years.


Revenue Growth

VOR's revenue has shown poor growth over the past 10 years, increasing by only 0%.

VOR FY, 2023 Revenue Breakdown

See how VOR converts it's revenue into profit.

VOR Balance Sheet Health

VOR Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

VOR financial position analysis

Short Term Liabilities

VOR's short term assets($141M) can safely cover it's short term liabilities($16M).

Long Term Liabilities

VOR's short term assets($141M) can safely cover it's long term liabilities($44M).

VOR Debt to Equity